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ABSTRACT
Coupled transcription and translation in bacteria are
tightly regulated. Some small RNAs (sRNAs) control
aspects of this coupling by modifying ribosome ac-
cess or inducing degradation of the message. Here,
we show that sRNA IsrA (IS61 or McaS) specifically
associates with core enzyme of RNAP in vivo and
in vitro, independently of  factor and away from
the main nucleic-acids-binding channel of RNAP. We
also show that, in the cells, IsrA exists as ribonucle-
oprotein particles (sRNPs), which involve a defined
set of proteins including Hfq, S1, CsrA, ProQ and
PNPase. Our findings suggest that IsrA might be di-
rectly involved in transcription or can participate in
regulation of gene expression by delivering proteins
associated with it to target mRNAs through its inter-
actions with transcribing RNAP and through regions
of sequence-complementarity with the target. In this
eukaryotic-like model only in the context of a com-
plex with its target, IsrA and its associated proteins
become active. In this manner, in the form of sRNPs,
bacterial sRNAs could regulate a number of targets
with various outcomes, depending on the set of as-
sociated proteins.
INTRODUCTION
The discovery of small non-coding RNAs in bacteria (sR-
NAs) that regulate translation and/or levels of particular
mRNAs by base-pair interactions together with proteins
such as the general RNA chaperone Hfq (1–3) is both as ex-
citing as the multitude of involved mechanisms is puzzling
(4). Translational regulation by sRNAs is often modeled as
an interference with ribosome binding by occlusion of the
ribosome binding site or the start codon just downstream.
Alternatively, sRNAs appear to induce degradation of the
message (1) but the exact mechanisms by which this occurs
are fairly speculative (4). In eukaryotes, small non-coding
RNAs also participate in many steps required in the con-
trol of gene expression. In the form of ribonucleoprotein
particles (RNPs) they assemble, for example, on precursor-
mRNAs (pre-mRNAs) or on ribosomal RNA precursors
(pre-rRNAs) in large complexes for the removal of introns
or external and internal transcribed spacers (in the case
of pre-rRNA) and post-transcriptional modification. These
small RNAs contain sequences that bind (a set of) core pro-
teins essential for the stability or function of the RNP, guide
the RNP to their target as well as take part in catalysis.
Target RNAmaturation steps are in part co-transcriptional
and, in the case of splicing, organized by factors associating
with the C terminal domain of RNA polymerase (RNAP)
(5–7).
Many of known sRNAs in bacteria regulate translation
by interacting with sequences of the mRNA and so mod-
ulate ribosome binding (1–3). In bacteria, on many genes,
translation is coupled to transcription (8–10), i.e. the ri-
bosome binds the nascent mRNA right behind the tran-
scribing RNAP. Recent study revealed that RNAP pauses
in the vicinity of the translation start site (11), possibly to
ensure proper coupling. This suggests a possibility that reg-
ulation of translation by sRNAs may also take place in a
co-transcriptional manner and perhaps involve interaction
of sRNA with RNAP. Indeed, RNAP has been reported to
interact with a number of sRNAs and proteins known to as-
sociate with them, such as Hfq or protein S1, a component
of the small ribosomal subunit (12–14).
The best-studied interaction of bacterial RNAP with a
non-coding RNA is that with 6S RNA, an 183 nt RNA that
binds the RNAP holo-enzyme by mimicking an open tran-
scription bubble, and, thus, regulates initiation of transcrip-
tion. 6S RNA accumulates when nutritional sources begin
to run out and cellular growth becomes stationary. During
exit from stationary phase, 6S RNA serves as a template for
RNAP and by generation of product RNA the polymerase
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gets released and becomes available for transcription (15).
Non-coding RNAs that regulate the elongating RNAP are
known only in eukaryotes. These include the U1 snRNA,
best known for its involvement in the formation of splicing
complexes (16), and the 7SK snRNA, which controls paus-
ing of RNAP downstream of the transcription start sites
of particular genes during transcript elongation and con-
tributes to termination (17–19).
In this work, we sought regulatory RNAs that would as-
sociate with RNAP.We identified a small non-coding RNA
that specifically interacts with core enzyme of RNAP at
a site distinct from the main nucleic acids binding cleft,
thus pointing to its possible role in transcription elongation.
This sRNA, IsrA, originally identified (but imprecisely) in
a bioinformatic screen for novel transcription units on the
chromosome as IS61 (20), has been found to interfere with
the expression of genes like csgD or flhDC, involved in the
multi-cellular adhesive lifestyle of E. coli and was renamed
to McaS (21,22). As, however, network analysis and sub-
sequent mutational analysis had implicated IsrA in DNA
repair (23) and not only in processes regulating motility
or biofilm formation (21,22), we prefer to use the original,
more general name for this sRNA. In addition to RNAP
core, Hfq, protein S1, CsrA, ProQ and PNPase, were also
found to associate with IsrA in vivo, suggesting that IsrA
may regulate translation as an RNP and possibly do so in a
co-transcriptional manner.
MATERIALS AND METHODS
Construction of strains and IsrA mutants
Parental and recombinant strains obtained as described be-
low are listed in the Supplementary Table. PCR reactions
were done with PhusionDNApolymerase (Finnzymes) and
primers from IDT.All gene-replacement constructs resulted
from ligation of a PCR-amplified, kinased fragment con-
taining the selectable marker and a gapped vector-fragment
obtained by inverse PCR of the plasmid in which the tar-
get gene had been cloned (see below). DNA templates were
removed by DpnI (NEB) digestion.
Strain with biotinylated RpoC. For one-step purification
of RNAP with streptavidin sepharose (GE Healthcare) the
biological active C-terminus of AccB, the biotin carboxyl
carrier protein (BCCP) (aa 71–156) (24)) was fused to
rpoC by means of a linker containing the cleavage site for
human rhino virus 3C (HRV3C) protease (LEVLFQ/GP).
Multiple rounds of Exponential megapriming PCR
(25) yielded an integration cassette based on plasmid
pAMD001 (26) in which the thyA gene was replaced by the
kanamycin resistance marker from pKD4 (27) that was am-
plified (using primers 5′-TTCAAGATCCCCTCACGCTG
and 5′-TTCAGAGCGCTTTTGAAGCTG) without
the FRT sequences (Supplementary Figure S1). The
BCCP-tagging cassette was amplified (with primers
5′-CGATATCGAAAGAGAACGTTATCGTG and 5′-
CATCCAACGCTCTAGATCTGTC), treated with DpnI,
and integrated into the rpoC locus of strain BW25113 using
the Red recombinase system (27). P1 lysates prepared
from kanamycin resistant recombinant cells with the
correct genomic insertions (as confirmed by colony PCR),
were used for horizontal transfer of accB-tagged rpoC to
other strains (Supplementary table).
Disruption of the chromosomal loci for Hfq and IsrA.
pGemT Easy (Promega) plasmids were constructed con-
taining the hfq ORF, which was amplified by PCR with
102 bp upstream and 84 bp downstream sequence from
MG1655, or the IsrA coding region including 394 bp up-
stream and 233 bp downstream sequence, amplified from
MG1655, JC7623 or RLrpoCHIS, which yielded pThfq or
pTisrA-M, −J or −R, respectively) (Supplementary Figure
S1D and S1E). In these plasmids, the coding regions 196–
282 or 16–282 of hfq and 3–56 of isrA were replaced with
the chloramphenicol resistance gene from pKD3 (amplified
with primers annealing to sites p1 and p2) (27) to obtain in-
tegration cassettes for maintaining the 65 aa core of Hfq
(hfq65) or for complete disruption of hfq and isrA genes.
Integration of the cassettes by means of Red recombinase
(27) was verified by colony PCR on chloramphenicol resis-
tant cells with, in the case of hfq disruption, an upstream
outer primer and c1 (27) or with up- and downstream outer
primers, and, in the case of isrA disruption, with c1 and an
upstream outer primer as shown in Supplementary Figure
S1 (panels D and E).
Strains carrying IsrA-mutants. Mutants of IsrA (shown in
Supplementary Figure S1F) were prepared by inverse PCR
of pTisrA-R. The plasmids were tested in vivo after transfor-
mation of strains lacking endogenous IsrA or used as tem-
plates for the production of T7 templates for in vitro RNA
synthesis.
Purification of RNPs through RNAP
Culturing of cells. Cells were grown on LB (10 g/l
tryptone, 5 g/l yeast extract, 10 g/l NaCl) with an-
tibiotics (100 g/ml ampicillin, 50 g/ml kanamycin
or 25 g/ml chloroamphenicol) as needed. For co-
immunoprecipitation experiments with His6-tagged RpoC
cells were grown to mid-exponential, early––or late station-
ary phase, washed with water and stored at −80◦C. For
co-immunoprecipitation experiments with BCCP-tagged
RpoC, cells were cultured in the presence of 100 mg/l biotin
(Sigma). Overnight grown pre-cultures were diluted 100-
fold into 150 ml medium and grown to an OD600 of ∼1.6–
1.9, after which the cells were harvested by centrifugation at
4◦C, washed three times with 50 ml cold PBS (8 g/l NaCl,
0.2 g/l KCl, 1.8 g/l Na2HPO4·2 H2O, 0.27 g/l KH2PO4)
and stored at −80◦C.
Purification of RNAP on nickel - or streptavidin sepharose.
Cell pellets were resuspended on ice in 15–20 ml binding
buffer (BB, 5% glycerol, 10 mM Tris–HCl pH 7.8, 1 mM
MgCl2 and, for binding to streptavidin sepharose, 1 mM
DTT) + 200 mM KCl (BB @ 200 mM KCl), 10 l Su-
perasin (Ambion), and EDTA-free Complete Protease In-
hibitor (Roche) and broken by four rounds of 1 min 30 s
sonication (power 30%, 1.5 s pulse on, 0.5 s off). Cell-debris
was removed by centrifugation (2× 10 min 7K rpm, 20 min
18K rpm) and the lysates were filtered over Millex-HV 0.45
m PVDF filter-units (Millipore) before mixing with Ni
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Sepharose 6 Fast Flow or Streptavidin Sepharose High per-
formance (GE Healthcare) beads. Extracts were incubated
for 2–16 h at 4◦C on a rotating wheel. To remove cellular bi-
otin and endogenous BCCP, streptavidin sepharose beads
were replaced after a pre-incubation period of 15–20 min.
Beads were washed extensively with BB@ 200mMKCl (in-
cluding 20 mM imidazole, pH 7.8 when RNAP was bound
to nickel sepharose), incubated with RNase-free DNAse
(Roche) for 20–40 min to remove bound DNA, and washed
with BB@200mMKCl+ 100g/ml heparin (Sigma) to re-
lease non-specifically bound RNA. RNAP was eluted from
streptavidin sepharose by incubation with HRV3C (Sigma)
for 16 h at 4◦C in BB @150mM NaCl (in the presence of
Superasin) and removed from nickel sepharose by digestion
with proteinase K (Fluka). RNA was isolated from eluates
by phenol–chloroform (Sigma), and chloroform (Sigma) ex-
tractions followed by ethanol precipitation in the presence
of glycogen (Roche) as a carrier. Alternatively, RNAs were
directly extracted from beads without enzymatic elution.
RNAs were dissolved in 15 l 15 mM Tris–HCl, pH 7.8
and stored at −20◦C. Proteins were precipitated from the
phenol-phase with acetone and dissolved in 15–30 l 10 M
urea. As an input control, total RNAwas isolated from 100
l extract and stored in 75 l 15 mM Tris–HCl, pH 7.8.
RNA identification. Of a 200 M stock, 0.33 l of a
mixed ribo-deoxyoligonucleotide with blocked 3′-end
([5Phos]rCrUrGGTAAGTCGACGCGTATCAAG-3ddC;
IDT) was ligated in a 5 l reaction to 2 l of the RNA
co-purified with RNAP in the presence of 0.33 l (6 u)
Superasin and 0.33 l (3 u) T4 RNA ligase (ssRNA ligase,
NEB) for 16 h at 15◦C. RNAwas purified from the reaction
by phenol–chloroform extraction and ethanol precipitated
in the presence of 0.3 M NaOAc, pH 5.2, and dissolved
in 6 l H2O. In an end-volume of 5 l, 2 l 3′-tagged
RNA was annealed to 0.5 l 100 M RT-PCR primer
(5′-TTGATACGCGTCGACTTACCAG) using a PCR
machine (5 min 70◦C, 5 min 4◦C) and cDNA was prepared
at 50◦C for 45–60 min in a 10 l reaction with 0.25 l (50
u) Superscript III (Invitrogen) or Revertaid (Fermentas)
reverse transcriptase, 2l 5×RT buffer (250mMTris–HCl,
pH 8.3, 30 mM MgCl2, 375 mM KCl, 50 mM DTT), 1 l
10 mM dNTPs (GE Healthcare), 0.5 l (10 u) Superasin.
The RT reaction included 0.5 l 100 M ‘Smart ligation
primer’ (5′-ATCAATGTACGCGTCGACCrArGrGrG)
to enrich for full-length products as described in the user
manual for the SMART cDNA Library Construction Kit
(Clontech). Alternatively, the 5′-adapter was ligated to
purified cDNA in a separate reaction. Excess primer was
removed by adding 0.5 l (10 u) exonuclease I (NEB) and
1.1 l 10× exonuclease I reaction buffer followed by a 30
min digestion at 37◦C. Synthesized cDNA was purified
as described above for 3′-end tagged RNA, taken up in
10 l H2O, and 2 l was amplified by 26–31 cycles of
PCR with Phusion DNA polymerase (Finnzymes), the
RT-PCR primer and a primer recognizing the 5′-adapter
(5′-ATCAATGTACGCGTCGACCAG). PCR products
in the range of 50–200 bp were gel-purified, kinased and
cloned into pGemT Easy (Promega) that was cut with
Ecl136 II (Fermentas) and treated with CIP (NEB). Clones
with an insert as found by MluI (Promega) digestion were
sequenced (by GATC-Biotech).
RNA analysis
Northern blotting. RNAs (4 g total RNA or 2 l of the
RNA co-purified with RNAP) separated on 10% polyacryl
amide with 8M urea in TBE (10.9 g/l Tris, 5.6 g/l boric
acid, 0.74 g EDTA) were blotted onto Hybond NX (GE
Healthcare) in 0.5× TBE using a Trans-blot Cell with plate
electrodes (NEB), crosslinked with UV and prehybridized
in SES1 (250 mM sodium phosphate pH 7.2, 7% SDS, 1
mM EDTA). Blots were hybridized overnight at 30◦C in
SES1 containing oligos against IsrA nt 4–26 or 6S nt 79–97
(of the mature, processed sRNA), which had been labeled
with T4 kinase (NEB) and [ -32P]-ATP (6000 Ci/mmol;
Hartmann), and purified on G50Micro Spin Columns (GE
Healthcare). Blots were washed three times 15 min in SES1,
exposed to a phosphor-imaging plate and analyzed using
ImageQuant software (GE Healthcare).
End labeling. In 4 l reactions, total RNA (0.5–1 g), 2
l of the RNA co-purified with RNAP or in vitro synthe-
sized RNA (0.2 g) were 3′ end labeled with 0.2 l [5′-32P]-
PcP (3000 Ci/mmol; Hartmann), 0.4l 10×T4RNA ligase
buffer, 0.4 l DMSO, 0.3 l T4 RNA ligase (NEB, Fermen-
tas) and 0.2l Superasin for 1–1.5 h at 37◦C.Likewise, the 5′
ends of RNAs were labeled with T4 kinase (NEB), 10× T4
kinase buffer and [u-32P]-ATP (6000 Ci/mmol; Hartmann)
in the presence of Superasin. Labeled RNAs were separated
on 10%polyacrylamide with 8Murea in TBE and fixedwith
50% methanol, 10% acetic acid. Dried gels were exposed to
a phosphor-imaging plate and analyzed using ImageQuant
software.
In vitro assays
Preparations of 70, RNAP (core) enzyme (isolated from
RLrpoCHIS or MG1655rpoCHIS that were kindly provided by
Robert Landick and Rachel Mooney; Supplementary Ta-
ble), and T7 RNAP transcribed RNAs (radioactively la-
beled with either [-32P]-GTP, [5′-32P]-PcP or [ -32P]-ATP
and gel-purified) were as described previously (28). Mass-
spectrometry (MS/MS) analysis of the RNAP preparations
was done to check for contamination with proteins such as
Hfq.
Electrophoretic mobility shift assays. EMSA in Figure 3A
was done as described previously (29). Note that no yeast
RNAwas added before complex formation as in the EMSA
experiments below.
EMSAs in Figures 3B and 4B, 4C were performed using
procedures adapted from (30,31). Before complex forma-
tion in the case of Figures 3B, 4B and C, for each sample,
0.5 pmol in vitro synthesized radioactively labeled substrate
RNA and, where indicated, 7–8 pmol specific competitor
RNA, were denatured in 15 mMTris–HCl pH 8 at 65◦C for
5 min and refolded at 37◦C for 10 min after adding 1 vol.
2× EMSA buffer (30 mM Tris–HCl pH8, 200 mM KCl, 2
mM MgCl2, 2 mM DTT) and put on ice. As a nonspecific
competitor, 1g purified total yeast RNA in 1×EMSAwas
added to all reactions prior to complexes formation.
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In all competition EMSA experiments, unlabeled com-
petitor RNA (where present) was always first combined
with 0.5–1 pmol of RNAP. Then, labeled RNAs were added
and the mixtures (with an end-volume of 5 l) were in-
cubated at 37◦C for 10–20 min and put on ice with 0.6
l 1 mg/ml heparin (to dissolve non-specific complexes).
When heparin was used as a negative control for complex-
formation it was added to RNAP before this was mixed
with RNA. After adding 2 l 50% glycerol to each sam-
ple, complexes were separated on 5% PAA in 0.5× TBE at
200 V with some bromophenol blue loaded alongside as a
migration marker. Gels were fixed, dried and analyzed as
described above.
Transcription assays. In vitro transcription assays with pu-
rified RNAP were done essentially as described previously
(29). In an end-volume of 8.5 l, RNAP (1–2 pmol) was
mixed with competitor (2–8 pmol RNA or heparin to 100
g/ml), 1 l 10× TB (200 mM Tris–HCl pH 7.8; 400
mM KCl; 10 mM MgCl2) and incubated for 5–10 min at
room temp to let complexes form.Reactions were started by
adding 1.5 l of a mix containing 1 mM each of CTP, ATP,
GTP, 0.1 mM UTP, 0.5 l [-32P]-UTP (3000 Ci/mmol;
Hartmann), 1 mM CpA and template DNA with the T7A1
promoter and T7-tr2 terminator; yielding∼100 nt-long and
∼170 nt-long products by termination and run-off tran-
scription, respectively. After 5 min incubation at 37◦C reac-
tions were stopped with 10 l formamide-containing load-
ing buffer. Where indicated, DNA template was allowed to
incubate with RNAP before inhibitor was added with the
reaction mix. Tri-nucleotide formation as a test for open
complex formation was done as above but the reaction mix
only contained template DNA, 0.5 l [-32P]-UTP (3000
Ci/mmol; Hartmann), 0.2 l 1 mMUTP and 0.05 l 5 mM
CpA. For the analysis of transcription elongation, elonga-
tion complexes containing 11 nucleotide-long RNA were
obtained in the reaction as above except nucleotide mixture
added to reaction contained 0.25 mM CpApUpC, 0.1 mM
ATP, GTP and 0.5 l [-32P]-GTP (3000 Ci/mmol; Hart-
mann). Elongation complexes were allowed to form for 10
min followed by addition of 2–8 pmol competitor and all
four NTPs to 200 M final concentration, for 5–10 min at
37◦C (28). Reactions were stopped with 10l loading buffer
and analyzed by denaturing PAGE and phosphorimaging.
Purification of RNPs through IsrA
Cell extracts from strains RL or RLrpoCCBBPisrA-
pisrA3tag (Supplementary Table), the latter transformed
with pGemT-IsrA3tag expressing IsrA with an optimized
‘StreptoTag’ (32) built into its 3′-terminal stem (Figure 1B,
Supplementary Figure S1F), were prepared as described
above in BB @ 200 mM KCl. RNPs were purified using
dihydrostreptomycin (Sigma) coupled to epoxy-activated
sepharose 6B (Sigma) following the procedures of (33,34),
and, after extensive washing with BB @ 250 mM KCl,
eluted with 200 M streptomycin (Melford) in BB @ 200
mM KCl. RNAs were isolated from the eluate by phenol-
chloroform extraction and ethanol precipitation; proteins
by TCA-precipitation. Proteins co-purified with IsrA-3tag
RNA were visualized by 4–20% SDS-PAGE. For LC/MS,
triplicate samples were run into the gel for 1–1.5 cm,
and cut-out in one slice each. Proteins were reduced with
DTT (Sigma), alkylated with iodoacetamide (Sigma) and
digested with modified trypsin (Promega). The digests were
analysed by LCMSMS using a Dionex U3000 nano-HPLC
system (Thermo) coupled to an Orbitrap LTQ XL(ETD)
(Thermo) mass spectrometer. Peptides were separated
on a 25 cm x 75 m PepMap column (Thermo) using a
67 min water acetonitrile gradient (0.08% formic acid).
Precursor ions were detected in positive mode at 350–1600
m/zwith a resolution of 60 000 (at 400m/z) and a fill target
of 500 000 ions and a lockmass was set to 445.120023
m/z. The 10 most intense ions of each MS scan (with a
target value of 10 000 ions) were isolated, fragmented and
measured in the linear ion trap. Peaklists in the Mascot
generic format (*.mgf) were generated using msconvert
(proteowizard.sourceforge.net) and the E. coliK-12, substr.
MG1655 genome was searched using X!Tandem and the
gpm interface (thegpm.org; version 2013.09.01.1) with
carbamidomethyl set as a fixed modification and Met
oxidation set as a variable modification. Two refinement
steps were included in the search to include deamidation
and methylation artefacts. The protein level false positive
rate (see: http://wiki.thegpm.org/wiki/False positive rate)
for all three repeats was <1%. The raw data have been
deposited at www.proteomeXchange.org.
Miscellaneous
Protein analysis. Proteins, taken up in 1 vol 2× loading
buffer (2% SDS, 80 mM Tris–HCl pH 6.8, 10% glycerol,
10 mM EDTA, 0.1% Bromophenol Blue, 200 mM DTT)
were analyzed on RunBlue precast 4–20% SDS-PAGE
(Expedeon) and stained with InstantBlue (Expedeon), a
Coomassie-based solution; Silver staining was done with
SilverXpress (LifeTechnologies). RNAP, partially purified
over a heparin column from BW-62, was used as a marker
for RpoA, B and C subunits.
Congo-red assay. For visualization of the amount of curli
present in the cell walls of stationary cells, 10-fold serial di-
lutions of cells were spotted on LB agar without NaCl con-
taining 20 g/ml congo red and 10 g/ml brilliant blue
(22) and grown at room temperature for 48 h. Plates were
scanned through the bottom against a dark background
on an Epson Perfection V700 Photo with ‘Color restora-
tion’ set. For contrast enhancement, levels were uniformly
changed and the non-relevant background converted to
black with the GNU Image Manipulation Program (www.
gimp.org).
Phylogenetic analysis. Sequences for sRNAs or ORFs,
including 200–300 bp up- or downstream, were retrieved
from EcoCyc (http://ecocyc.org) and homologs iden-
tified by iterative Blast searches (with filtering off and
expectation >10) against (selected) bacterial genomes
at https://asap.ahabs.wisc.eduasap/sim search query.php
or http://www.ncbi.nlm.nih.gov/sutils/genom table.cgi?
organism=microb (when a choice of organisms from
a list was still available). Alignments were prepared
with CLC Sequence Viewer 6.9 (http://www.clcbio.com)
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Figure 1. A small non-coding RNA, IsrA, co-purifies with RNA polymerase. (A) Pull-down of RNAs with 6xHis-tagged (strain RLrpoCHIS) or tag-less
RNAP onNi2+-NTA sepharose. Isolated RNAs were 5′- or 3′ end labeled and analyzed as described in theMaterials andMethods. (B) Secondary structure
model of the purified RNA, identified as IsrA ((23); a.k.a. IS61 (20) orMcaS (21,22)) which was based on phylogenetic analysis (see Supplementary Figure
S2). An extension that substitutes the outer portion of stem 3 and provides affinity to streptomycin (streptotag (32); see Figure 2) is boxed. (C) Summary of
IsrA structure in sequence logo representation; height of nucleotides mark the degree of conservation. Base pairs that form stems are indicated by brackets;
rectangles indicate regions implicated in protein binding (CsrA), or translational regulation of flhDC, or csgDmRNAs (21,22,43). (D) Purification ofRNAP
on streptavidin sepharose through a biotinylated tag at the ’ subunit that can be cleaved off usingHRV3C (3C) protease. RNAPswere isolated from strains;
lane 1: RLisrA-pisrA (tag-less RNAP, IsrA under mutant promoter on multi-copy plasmid); lane 2: RL (tag-less RNAP, genomic IsrA under mutant
promoter); lane 3: MG1655rpoCBCCP (BCCP-tagged RNAP, genomic IsrA under wild-type promoter); lane 4: JC7623rpoCBCCP (BCCP-tagged RNAP,
genomic IsrA under wild-type promoter); lane 5: RLrpoCBCCP (BCCP-tagged RNAP, genomic IsrA under mutant promoter); lane 6: RLrpoCBCCPhfq65
(BCCP-tagged RNAP, genomic IsrA under mutant promoter, Hfq lacks C-terminus) (see also Supplementary Table). Relative expression levels of IsrA are
shown above the gels (expressed from wild-type promoter in chromosomal locus (+), expressed from a mutant promoter in the chromosomal locus (++)
or from mutant promoter from a high-copy plasmid (+++)). RNAPs were released by HRV3C (3C) cleavage and analyzed by SDS/PAGE on a 4–20%
gradient gel. Strains that have RNAPwithout a biotinylated tag were used as a control. Lanes 7 and 8 are controls for non-specific binding to and efficiency
of release from beads of RNAP in lanes 1 and 5, respectively. (E) Northern blot analysis of RNAs that co-purified with biotinylated RNAP in panel (D).
The blots were probed against IsrA (bottom) or 6S RNA (top). Indicated are the presence of the biotinylated affinity tag on RNAP ’ (+ or – tag), the
expression levels of IsrA in the input extract (as in panel (D)), and whether Hfq in the cells was truncated to its core of 65 amino acids (C) or was wild
type (+).
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using ClustalW (http://www.clustal.org/clustal2/) or
MUSCLE (http://www.drive5.com/muscle/) algorithms,
MAFFT (http://mafft.cbrc.jp/alignment/server) and
Jalview 2.8 (http://www.jalview.org/); secondary struc-
tures were analysed with RNAfold or RNAalifold
(http://rna.tbi.univie.ac.at/) and promoter sequence speci-
ficity for the IsrA gene was assessed with RegulonDB
(http://www.ccg.unam.mx/Computational Genomics/
PromoterTools/). Sequence logos were created at
http://weblogo.berkeley.edu.
RESULTS
A small non-coding RNA IsrA co-purifies with RNA poly-
merase
Recent examples of non-coding RNAs that interfere with
transcription by RNA polymerase (RNAP) (17) stimulated
us to check whether in bacteria other RNAs than 6S RNA
can regulate the activity of this multi-subunit enzyme. In
a preliminary experiment we bound cellular RNAP to a
Ni2+-NTA sepharose column by means of a 6× histidine
affinity-tag attached to the C-terminus of the ’ subunit
(chromosome encoded; strain RLrpoCHIS, see Supplemen-
tary Table). After multiple washing steps (using solutions
containing 200 mMKCl, 10 mM imidazole and 100 g/ml
heparin) RNAs associated with the bound fraction were pu-
rified. Two RNAs, of about 180 and 90 nt, were isolated
which were not present in preparations from cells express-
ing untagged RNAP ’ (Figure 1A, cf. lanes 2 and 3). Af-
ter attaching a linker to their 3′ ends (see Materials and
Methods), the RNAs were amplified by RT-PCR, cloned
and sequenced. This identified the two RNAs as 6S RNA
(15,31,35) and IsrA (Figure 1B, C)(23) whichwas confirmed
by Northern blotting (e.g. Figure 1E). RNA degradation or
processing in the extracts after breaking the cells, was lim-
ited: cDNA products were obtained that covered the com-
plete IsrA sequence (94 nt, including the 7 U’s at the 3′ end)
and partially processed forms of 6S RNA (of 191–197 nt)
which, in its mature form, is 183 nt. Furthermore, both 6S
and IsrA could be labeled at their 3′ ends (Figure 1A, lane
4), indicating the absence of a 3′ phosphate characteristic
of hydrolytic degradation. The 5′ end of IsrA is protected
from phosphorylation by T4 PNK likely by a triphosphate
group characteristic for primary transcripts, whereas pro-
cessed 6S RNA was phosphorylatable (Figure 1A, lane 5).
Both 6S RNA and IsrA could be released from Ni2+-NTA
sepharose by proteinase K digestion, indicating that a pro-
tein (likely RNAP) determines the binding of these RNAs
to the matrix.
The majority of cloned cDNAs derived from IsrA and 6S
RNA, which indicated specific interactions. Protein analy-
sis of the fraction that remained bound to the nickel col-
umn, however, showed that a number of other proteins were
isolated together with RNAP. To ensure that IsrA bound
specifically toRNAP, the purification was repeated using an
alternative affinity-tag on RNAP ’. For this, we used the
biologically active C-terminal region of the biotin carboxyl
carrier protein (BCCP; (24)) which was linked to RNAP ’
via a peptide containing the cleavage site for the human
rhinovirus 3C (HRV3C) protease (Supplementary Figure
S1A; strain RLrpoCBCCP). Extracts were prepared from cells
grown in the presence of biotin and mixed with streptavidin
sepharose beads. After extensive washes in the presence of
100g/ml heparin, RNAP that was bound to the beads was
released by HRV3C cleavage. This procedure yielded large
amounts of RNAP from strain RLrpoCBCCP (Figure 1D, lane
5). Northern blot analysis confirmed that both 6SRNAand
IsrA co-purified with RNAP (Figure 1E, lane 11). In ab-
sence of tagged RNAP no significant binding of proteins
or RNAs to streptavidin sepharose was observed as shown
by control purifications using the parental strain (RL), or
a derived strain in which IsrA was overexpressed from a
high-copy plasmid (RLisrA-pisrA) (Figure 1D, lane 1, 2
and Figure 1E, lanes 7, 8). We therefore conclude that IsrA
specifically co-purifies with RNAP.
We noted differences in growth-dependent expression
of IsrA in the RL-based strains used above (RLrpoCHIS,
RLrpoCBCCP) and the commonly used MG1655, which
was explained by a point mutation in the IsrA pro-
moter (see Supplementary Text). However, we showed that
IsrA readily co-purified with BCCP-tagged RNAP from
MG1655rpoCBCCP and JC7623rpoCBCCP (the mutation-less
parent of RL strains) cells (Figure 1D, E; Supplementary
Text and Supplementary Table), demonstrating that the as-
sociation of IsrA with RNAP is strain-independent.
Bioinformatics analysis showed that IsrA appears to be
expressed in a subset of enterobacteria (Supplementary Fig-
ure S2) and can be modeled to adopt a secondary struc-
ture with three stem-loops (Figure 1B). The 5′ third of the
molecule covering stem 1 is highly variable and only align-
ments that included the promoter region revealed the puta-
tive 5′ ends of IsrA homologs (Supplementary Figure S2A).
Phylogenetic analysis, backed up by lowest-energy calcula-
tions (Supplementary Figure S2C) suggested two stems in
the 3′ portion of the sRNAwhich stand out by conservation
in the 3′ half of stem 2 and the loop of stem 3 (Figure 1C;
Supplementary Figure S2B). As will be seen below, stem 2
determines specific interaction of IsrA with RNAP.
In vivo IsrA exists as an RNP with proteins S1, Hfq, ProQ,
PNPase, CsrA and RNAP
To further investigate association of IsrA with RNAP we
used a reciprocal approach, by pulling down proteins from
the cell via a tagged IsrA. This approach would also provide
information on the proteins associated with an IsrA/RNAP
complex. Because we found that stem 3 was not essen-
tial for the interaction with RNAP (see below) this stem-
loop was partially substituted with an affinity tag, strep-
totag, that specifically binds to streptomycin (32) (Figure
1B). Tagged IsrA was expressed from its own promoter on
a multi-copy vector in a strain lacking the endogenous IsrA
(RLrpoCBCCPisrA-pisrA3tag, Supplementary Table). Full-
length IsrA-3tag RNA co-purified with biotinylated RNAP
on streptavidin sepharose (Supplementary Figure S3), in-
dicating that the tag neither inhibited the interaction with
RNAP nor seriously affected termination of IsrA transcrip-
tion.
From the same cells we purified tagged IsrA on a di-
streptomycin-matrix (13,34) (Figure 2B). As described pre-
viously (13), non-specific binding of proteins to the di-
streptomycin-matrix was negligible (Figure 2A, lane 4). In-
 at U
niversity of N
ew
castle on January 4, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015 7
Figure 2. RNAP and a defined set of proteins co-purify with IsrA carrying a streptotag. (A) Streptotagged IsrA-3tag (see Figure 1B) and proteins associated
with it were isolated on di-streptomycin beads from strain in which the endogenous gene for IsrA was disrupted (strain RLrpoCBCCP isrA-pisrA3tag, see
Supplementary table). Co-purifying proteins (Strepto lanes) were analyzed by SDS-PAGE on 4–20% gradient gels and stained with Coomassie or silver
as described in the Materials and Methods. Mock isolation with the di-streptomycin beads using the parental strain with untagged IsrA (RL; lane 4) was
used as a negative control. The presence and absence of affinity tags on IsrA is indicated by + and –, respectively. RNAP purified on a heparin column
from strain BW-62 was used as size control (RC; lane 3). (B) RNA was analyzed by Northern blotting with an IsrA-specific probe. Note that the blot is
overexposed to make the IsrA band in the input visible. The presence and absence of affinity tags on IsrA is indicated by + and –, respectively.
terestingly, only a limited set of proteins co-purified with
streptotagged IsrA (Figure 2A, lanes 5, 6). Using GeL-
CMSMS, we analyzed all the proteins that co-purified with
IsrA. This resulted in high confidence identifications of sev-
eral proteins in the major bands that are visible on the SDS-
PAGE gel (Figure 2A; and Table 1, and Supplementary
Data SD1). Indeed, subunits of RNAP (,  and ’) were
present in the pull-down in abundance (even clearly visible
in the SDS gels; Figure 2A, lanes 5 and 6), supporting our
conclusions that IsrA specifically associates withRNAP. In-
triguingly, however, we observed other proteins in amounts
comparable to RNAP subunits (Table 1), represented by
RNA chaperones Hfq (36) and ProQ (37,38), protein S1
(39), PNPase (40,41), and CsrA (42). CsrA and Hfq, but no
other proteins, were previously shown to associate with IsrA
(21,43). Less represented proteins that were detected by
mass-spectrometry comprised some ribosomal proteins (r-
proteins), tRNA modification enzyme DusA (44), poly(A)
polymerase (PAP I; (45,46)), RNase G (47), a subunit of
the membrane associated ATP-synthase, the Lon protease,
lipoprotein Entericidin B, and putative transcription fac-
tor YhgF. Overall, the limited number of proteins that co-
purified with IsrA indicate that this RNA forms particular
complexes, at least one of which involves RNAP. Interest-
ingly, no -subunit of RNAP was found in the pull-down,
suggesting that IsrA may regulate core enzyme of RNAP,
an idea signified by our finding that IsrA can specifically
interact with core (see below).
Interaction of IsrA with RNAP does not depend on Hfq-
mediated mRNA(s) binding in vivo
Hfq, a general RNA chaperone that confers stability
to sRNAs that terminate in a rho-independent manner
(36,48,49), was overrepresented in the above pull-down
through tagged IsrA. As reported previously (22), in strains
lacking Hfq, IsrA could not be detected indicating that Hfq
is required for IsrA stability (not shown). Note also that
the majority of IsrA isolated via the streptotag remained
intact with only minor nicked species (Figure 2B), suggest-
ing that most of IsrA in the cell exists as an RNP, in which
it is associated with at least Hfq. The N-terminal 65 amino
acids of Hfq are sufficient to support formation of the hex-
americ Hfq-ring and the binding to sRNAs, while the re-
maining C-terminal tail is required for the binding of two
RNAs and possibly their annealing (50–52). It is possible
that IsrA is associated with RNAP via Hfq-mediated inter-
action with mRNAs. However, deletion of the C-terminal
tail from Hfq (strain RLrpoCBCCPhfq65) did not affect the
stability of IsrA or its association with RNAP (Figure 1E,
lanes 6 and 12). IsrA is amajor player in the control of curli-
synthesis (21,22,53), because when there is no IsrA present,
curli (red-color in Supplementary Figure S4) is produced.
The C-terminus of Hfq is also essential for IsrA-controlled
regulation of translation; curli-synthesis was not inhibited
in cells having the truncated form of Hfq (Supplementary
Figure S4). These results indicate that the C-terminal do-
main of Hfq, while being required for IsrA function in the
cell, possibly via assisting base pairing with target mRNA,
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Table 1. Proteins co-purifying with streptotagged IsrA-3tag were assigned based on comparison and identification bymass-spectrometry, done in triplicate
Accession Ecoli # Gene Protein Mr log(e) # Description
gi|16128878 b0911 rpsA S1 61.1 −299.83 125 30S r-protein S1; translation initiation factor.
gi|16131994 b4172 hfq Hfq 11.2 −296.6 362 RNA chaperone; host factor for phage Q 
replication.
gi|49176156 b1831 proQ ProQ 25.9 −238.23 128 RNA chaperone; regulator of ProP expression.
gi|145698316 b3164 pnp PNPase 77.1 −130.1 44 polynucleotide phosphorylase or - polymerase.
gi|16131817 b3987 rpoB RNAP  150.5 −106.33 33 RNA polymerase;  subunit.
gi|16131174 b3295 rpoA RNAp  36.5 −66.87 28 RNA polymerase;  subunit.
gi|16131602 b3734 atpA AtpA 55.2 −66.33 23 F1 sector of membrane-bound ATP synthase.
gi|90111550 b3162 deaD CsdA 70.5 −65.8 22 ATP-dependent RNA helicase.
gi|16130603 b2696 csrA CsrA 6.9 −57.03 38 Regulatory protein for carbon source metabolism.
gi|16131818 b3988 rpoC RNAP ’ 155.1 −51.13 19 RNA polymerase; ’ subunit.
gi|145698340 b4049 dusA DusA 36.8 −42.73 16 tRNA-dihydrouridine synthase A.
gi|16128424 b0439 lon Lon 87.4 −41.2 17 DNA-binding ATP-dependent protease.
gi|90111563 b3247 rng RNaseG 55.3 −12.93 7 (Endo) ribonuclease G.
gi|162135892 b0143 pcnB PAP I 53.8 −12.4 9 Poly(A) polymerase.
gi|49176463 b4411 encB EncB 4.8 −12.4 3 Entericidin B; translationally repressed by MicA.
gi|90111588 b3407 yhgF YhgF 85.1 −11.9 4 Has C-terminal S1; predicted to assist transcription.
gi|16131143 b3255 accB BCCP 16.7 −9.23 4 C-term of BCCP, used as an affinity tag on RNAP ’.
gi|16131220 b3341 rpsG S7 20 −73.23 30 30S r-protein S7.
gi|16131814 b3984 rplA L1 24.7 −62.23 26 50S r-protein L1, also translational regulator.
gi|16131193 b3314 rpsC S3 26 −50.23 22 30S r-protein S3.
gi|16131182 b3303 rpsE S5 17.6 −40.9 17 30S r-protein S5.
gi|16131177 b3298 rpsM S13 13.1 −40.8 20 30S r-protein S13.
gi|16131120 b3230 rpsI S9 14.8 −40.17 19 30S r-protein S9.
gi|16131175 b3296 rpsD S4 23.5 −39.4 24 30S r-protein S4, also translational regulator.
gi|16132025 b4203 rplI L9 15.8 −36.17 13 50S r-protein L9.
gi|16131180 b3301 rplO L15 15 −35.57 13 50S r-protein L15.
gi|16128162 b0169 rpsB S2 26.7 −25 15 30S r-protein S2.
Their molecular mass in kDa (Mr), the average base-10 log of the expectation that any particular protein assignment was made at random (log(e)) and the
total number of peptides (#) identified for each protein are indicated.
is not needed for the association of IsrAwithRNAP. The re-
sult cannot exclude association of IsrAwithRNAP through
its interaction with mRNA that potentially may also be
pulled down with RNAP. However, as will be seen below
IsrA can specifically associate with purified core enzyme of
RNAP.
IsrA binds specifically to core and holo RNAP in vitro
During the pull-down experiments described above, the in-
teraction of IsrA with RNAP can be indirect and be me-
diated by other proteins that co-purify with IsrA, such as
Hfq that has been isolated with RNAP (12). In order to
investigate this possibility we synthesized IsrA in vitro by
means of T7 RNAP and, after labeling and gel-purification,
analyzed its binding to purified core and holo RNAPs by
electromobility-shift assays. Core enzyme and 70 were pu-
rified to apparent homogeneity using stringent procedures
(28), andmass-spectrometry did not detect any contaminat-
ing proteins such as Hfq. As negative and positive controls,
binding reactions of RNAP with tRNAAla and 6S RNA
were set up (Figure 3).
Both, RNAP core and holo enzymes bound either of the
RNAs (Figure 3A, lanes 2, 7 and 9, 14 and 16, 21). In
fact, IsrA was bound more efficiently than 6S or tRNAAla
(which we attribute to two modes of binding, specific and
non-specific; see below).However, RNAPhas a high affinity
for any nucleic acid, and to increase stringency for complex
formation we used the polyanion heparin. Heparin tightly
binds to RNAP and causes non-specific and/or weak com-
plexes to fall apart, even if added after complex formation.
As expected, when heparin is added before the RNA, no
complex formation is observed even with holo RNAP (Fig-
ure 3A, lanes 5, 12 and 19). tRNAAla that does not bind
RNAP specifically lost its association with either core or
holo RNAPs on subsequent exposure to 100 g/ml hep-
arin (Figure 3A, compare lanes 1 and 6 to 2 and 7). In
agreement with published data (31,35), we found that 6S
RNA only forms specific, heparin-resistant complexes with
the holo enzyme (Figure 3A, compare lanes 8 and 13 to
9 and 14). Surprisingly, IsrA formed heparin-resistant, i.e.
specific, complexes with both core and holo enzymes (Fig-
ure 3A, compare lanes 15 and 20 to 16 and 21).
6S RNAmimics nucleic acids in the promoter open com-
plex, while tRNAAla likely binds in the main channel of
RNAP. Accordingly addition of a strong T7A1 promoter
to RNAP prior to tRNAAla or 6S prevented or diminished
formation of complexes with these RNAs (Figure 3A, com-
pare lanes 3 and 10 to 7 and 14). In contrast, while addition
of T7A1 before IsrA destructed part of the complexes as did
heparin, a large amount of IsrAwas still able to form a com-
plex with RNAP (Figure 3A, compare lane 17 to 21). This
result suggested that the specific IsrA binding site onRNAP
is different from that of promoter DNA and 6S RNA. This
was confirmed by competition experiments in which an ex-
cess of unlabeled 6S RNA prevented association of labeled
6S RNA with RNAP (Figure 3B, lane 3) but did not in-
terfere with the binding of labeled IsrA (Figure 3B, lane 7).
Reciprocally, unlabeled IsrA could replace only labeled IsrA
(Figure 3B, lane 6). Note that, in all reactions contained to-
tal yeast RNA as a non-specific competitor, and heparin
was added to all reactions after complex formation, thus
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abolishing non-specific complexes of RNAs with RNAP.
Accordingly, an extra presence of non-specific competitor
5S rRNAmade no difference to RNAP complex formation
of either 6S RNA or IsrA (Figure 3B, lanes 4, 8). We con-
clude that IsrA can directly interact with RNAP at a site not
required for or interfering with promoter or 6S RNA bind-
ing, i.e. away from the main nucleic-acids-binding channel
of RNAP.
We also noted that specific 6S RNA/holo complexes mi-
grated considerably slower than non-specific 6S RNA/core
or specific IsrA/core and IsrA/holo complexes, which be-
tween them had similar mobility in the gel. It is possi-
ble that, because of the different binding sites of 6S RNA
and IsrA, specific 6S RNA/holo complexes have a different
conformation to those of IsrA/holo and IsrA/core, which
changes the migration in the gel. Another possible explana-
tion is that specific 6S RNA/holo complexes migrate more
slowly due to the presence of the 70 subunit, while IsrA
may induce the release of the 70 subunit from the holo
RNAP (and turn the complex into IsrA/core). However,
both possibilities require further investigation.
Stem 2 of IsrA is needed for specific interaction with RNAP
The finding that IsrA could only compete against itself for
RNAP association suggested that particular structural el-
ements of this sRNA are responsible for this interaction.
By testing a set of IsrA mutants (Figure 4A; Supplemen-
tary Figures S1F, S6A, S5) we obtained evidence that stem
2 is important for the in vitro binding of IsrA to RNAP.
Whereas disruption of the linker between stems 1 and 2
(B) or of stem1 (1) had no negative effect on complex
formation with RNAP, this was completely abolished on re-
moval of stem 2, while a comparably large deletion of stem
3 (3) had much less effect (Figure 4B). Note that only spe-
cific interactions of IsrAwith RNAPweremonitored in this
experiment, as heparin was present in all reactions. Com-
petition experiments showed that only mutants that bound
RNAP were able to compete for the IsrA binding site with
full-length labeled IsrA, and to an extent that correlated
with their RNAP affinity (Figure 4C); the linker mutant
(B) could fully compete, the stem 1 disruptant (1) par-
tially and the sRNA lacking stem 2 (2) not at all.
To test whether stem 2 of IsrA determines interaction
with RNAP in vivo, we either removed stem 2 or intro-
ducedmutations in loop 2 of the overexpressed IsrA (strains
RLrpoCBCCPisrA-pisrAiΔ2, RLrpoCBCCPisrA-pisrAi2loop),
and compared their co-purification with RNAP to mutant
IsrA lacking the single stranded region separating stems 1
and 2 (strain RLrpoCBCCPisrA-pisrAΔB), which does not
affect RNAP binding in vitro. As seen fromFigure 4Dwhile
the linker deletion was neutral, mutations in or removal
of stem 2 prevented enrichment of the mutant IsrA in the
RNAP fraction. This result corroborates our in vitro data
that IsrA specifically interacts with RNAP via its stem 2.
Only non-specific interaction of IsrA with RNAP inhibits ini-
tiation of transcription in vitro
We observed considerable non-specific binding of IsrA to
RNAP (Figure 3A, lanes 16, 18 and 21), which was read-
ily abolished by pre-incubation of RNAP with promoter
DNA or by treatment of IsrA-RNAP complexes with hep-
arin (Figure 3A, lanes 15, 17 and 20). However, addition of
promoter DNA after these non-specific complexes formed
did not lead to their destruction (Figure 3A, cf. lanes 17,
18). Accordingly, we observed that addition of IsrA before
the promoter in the in vitro transcription reaction resulted in
inhibition of transcription (Figure 5A lane 4), similar to the
expected inhibition observed after pre-incubation of RNAP
with 6S RNA (Figure 5A, lane 5). The stringency of IsrA
binding in in vitro transcription could not be tested by addi-
tion of heparin (as we did in all other experiments), because
heparin would inhibit transcription on its own. However,
the following observations argue that the heparin-resistant
specific binding of IsrA to RNAP does not affect binding
of promoter DNA: (i) Stem 2 of IsrA is required for spe-
cific, heparin-resistant binding to RNAP (Figure 4B and
C). However, 2 IsrA is still able to inhibit transcription
initiation when added before promoter, indicating that it is
the non-specific mode of binding of IsrA that is responsi-
ble for inhibition (Figure 5C, lane 6); (ii) In the presence
of radioactive NTPs, IsrA was radiolabelled at the 3′ end
by RNAP in a template-independent manner, suggesting its
binding at the active center cleft, which likely causes inhibi-
tion of initiation. However, such end-labeling was also ob-
served with 2 IsrA, which cannot bind RNAP specifically
(Figure 5C). In addition, if the 3′ end of IsrA was binding
specifically in the active site of RNAP then one would ex-
pect the 3′ end of IsrA to be strictly required for binding.
This however is not the case as the mutant IsrA lacking the
whole 3′ proximal part (3 in Figure 4A) is still able to form
heparin-resistant complexes with RNAP (Figure 4B, lane
3). (iii) Unlike any other known sRNA binding to RNAP,
IsrA is able to bind RNAP after open complex formation
and, apparently, not to compete with 6S RNA (Figure 3A,
lane 17 and Figure 3B, lanes 2, 7), indicating that its binding
site is different from the main nucleic-acids-binding cleft of
RNAP. Accordingly, no 3′ end labeling has been seen when
IsrA was added after open complex formation (Figure 5A,
lane 6). This mode of IsrA binding however did neither af-
fect transcription initiation nor elongation (Figure 5A, lane
6; B, lane 4).
These facts indicate that the observed inhibition of tran-
scription initiation is caused by non-specific binding of IsrA
to RNAP, which apparently interferes with promoter DNA
binding. In the cells, however, IsrA likely exists as an sRNP
(see above), which would suppress non-specific binding to
RNAP. In agreementwith this idea,mutations in or deletion
of the Stem 2 of IsrA (which determines only specific in-
teraction) strongly diminished co-purification with RNAP
from cells in comparison to mutant B (Figure 4D, cf. lane
8 to 9, 10) which strongly bound RNAP in vitro (Figure 4B,
lane 4). This indicates that predominant in cells is the spe-
cific, stem 2-mediated, interaction of IsrA with RNAP that
does not interfere with initiation of transcription. This fur-
ther is supported by the fact that overexpression of IsrA in
cells does not affect their growth (e.g. Supplementary Fig-
ure S4, row 5).
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Figure 3. IsrA specifically binds core enzyme of RNAP. (A) Electrophoretic mobity shift assay (EMSA) with radioactively labeled, gel-purified T7 synthe-
sized 32P-labelled RNAs (tRNAAla, 6S RNA or IsrA) which were mixed with equimolar amounts of purified core or holo (70) enzymes of RNAP. The
labeled RNA and a competitor (T7A1 promoter DNA or heparin) were added to RNAP first (+*) or second (+). (B) Competition of various unlabeled
RNAs with 32P-labeled 6S RNA and IsrA. 15-fold excess of unlabeled competitor RNA (Supplementary Figure S5) was added to RNAP before addition
of labeled RNAs. All reactions contained total yeast RNA as a non-specific competitor prior to complex formation. Heparin was added to all reactions
before loading on the gel to dissolve non-specific complexes.
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Figure 4. Stem 2 of IsrA is required for specific binding to RNAP. (A) Mutant versions of IsrA (see also Supplementary Figure S1F) shown as a black line-
diagram with deleted regions indicated in white. In the i2loop mutant the loop closing stem 2 has been replaced with GAAG (gray; see also Supplementary
Figure S6A). (B) EMSA of RNAP and mutant labeled IsrA RNAs with heparin added before (+*) or after (+) complex formation. All reactions contained
total yeast RNA as a non-specific competitor prior to complex formation. (C) Competition of unlabeled mutant IsrA RNAs (15-fold molar excess) with
labeled wild-type variant. Unlabeled competitor RNA was always added before complex formation of RNAP with labeled RNA. All reactions contained
total yeast RNA as a non-specific competitor prior to complex formation. Heparin was added in all reactions after formation of complexes. Only IsrA
mutants that are able to bind RNAP in the presence of heparin (see panel B) compete against association of labeled IsrA. (D) Northern blot analysis of
mutant IsrA RNAs that co-purified with RNAP (for protein gel see Supplementary Figure S6B. Plasmids from which the mutant IsrA RNAs (see panel A)
were expressed, along with an empty vector (pGemT), were transformed into strain RLrpoCBCCPisrAwith a disrupted IsrA gene and carrying biotinylated
RNAP. A strain expressing RNAP without the biotinylated tag (RLisrA-pisrA(*)) was used as a negative control (input and pull-down are overloaded).
sRNAs were released from beads with 3C, and the blots were probed against IsrA (bottom) or 6S RNA (top). Below the blot, quantitation of the bands
corresponding to IsrA mutants (encircled in the blot), normalized to the corresponding bands of 6S RNA.
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Figure 5. Only non-specific binding of IsrA to RNAP can inhibit transcription. (A) Transcription on a linear template containing the T7A1 promoter.
The order in which RNAP was allowed to associate with the promoter DNA or competitor RNA is given (+* added first; + second). Note the template-
independent labeling of IsrA at the 3′ end by RNAP, which suggests non-specific binding near the active center of RNAP (see text). (B) Pre-formed 11-mer
elongation complexes were chased in the presence or absence of sRNAs. (C) Abortive synthesis of CpApU on T7A1 promoter. Mutant IsrA RNAs or
heparin were added before promoter DNA. Note that the IsrA variant 2, which cannot bind RNAP specifically, still inhibits initiation and is labelled at
the 3′ end (see text for details).
DISCUSSION
Here, we present evidence that a small non-coding RNA,
IsrA, specifically associates with core enzyme of RNAP (via
its stem 2) and does so at a different site and mode than 6S
RNA. This is the first example of specific interaction by a
sRNA and bacterial RNAP that takes place away from the
main nucleic acids binding channel and is independent of 
factor. The data also suggest that IsrA provides a scaffold
for binding of a specific set of proteins, though whether this
function is associated with its ability of binding RNAP or
represents a separate function of IsrA is not yet clear and is
discussed below.
Whether IsrA acts as a transcriptional regulator in vivo
remains to be seen. It is unlikely that it inhibits transcrip-
tion in a manner 6S RNA does, as only non-specific bind-
ing of IsrA to RNAP, which does not happen in vivo, affects
initiation (see the last section of the Results). Uniquely, spe-
cific binding of IsrA does not require  factor (because it
forms heparin-resistant complexes with core enzyme, and 
is not pulled-down with tagged IsrA from cells) and hap-
pens away from the main channel of RNAP (because IsrA
binding is compatible with promoter and 6SRNAbinding).
On a conventional template (containing phage T7 promoter
A1), specifically bound IsrA has no apparent effect on tran-
scription (Figure 5A, lane 6 and B, lane 4). It is however
possible that IsrA bound to initiating or elongating RNAP
at a specific gene may directly affect transcription, for ex-
ample, by base pairing with the nascent RNA or the DNA
strands (Figure 6A). It is also possible that IsrA may par-
ticipate in regulation of RNA dependent pausing and/or
termination through interactions with RNA hairpins in the
nascent RNA or affecting the conformational changes of
RNAP on these signals (Figure 6A). Finally, as discussed
below, IsrA can be delivered to mRNAs by RNAP to regu-
late their translation (Figure 6B).
The limited number of proteins that co-purified with IsrA
indicates that this RNA forms particular sRNA-protein
complexes. Therefore, another possible function of IsrA is
bringing, via base pairing with the target RNA, proteins as-
sociated with it for regulation of translation and/or degra-
dation of the target RNA (Figure 6B).We suggest that base-
pairing interactions between target and regulatory RNAs
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Figure 6. Hypothetical model of co-transcriptional functions of sRNPs formed by IsrA, and possibly other sRNAs. (A) Transcription regulation. IsrA
stabilized by protein(s) such as Hfq and/or S1 binds specifically to core enzyme of RNAP via its stem 2, with or without the release of the proteins.
During transcription elongation IsrA may be involved in regulation of transcription through interactions with nucleic acids of the elongation complex
or by changing RNAP response to regulatory signals. (B) Translation regulation (note that shown is co-transcriptional regulation of translation, though
our data do not exclude regulation that is independent of RNAP). sRNA associates with one or a set of proteins form sRNPs as directed by cellular
requirements. Protein(s) of the sRNP remain silent until they are delivered to the target mRNA. The sRNP can associate with elongating RNAP (via
stem 2 of IsrA), as suggested by our data, which would make its delivery to the target mRNA more efficient. Target mRNA is recognized via limited
complementarity with the sRNA. Recognition of the target facilitates delivery of the protein(s) of the sRNP, which, depending on the set of proteins,
determine the fate of the mRNA, such as activation or inhibition of translation or degradation of the mRNA. The sRNA can participate in the regulation
of the mRNA along with the proteins or is released.
might not be the main driving force for regulation of all
these mRNAs. For example, stem 2 of IsrA has been shown
to base-pair with the csgD mRNA, resulting in its transla-
tional down-regulation, while the sequence of the loop clos-
ing stem 3 mediates up-regulation of flhDCmRNA transla-
tion (21,22). The proposed mechanisms in which base-pair
interactions between IsrA and the target mRNAs free or
block the ribosome binding-site or start-codon, however,
are poorly supported by phylogenetic evidence (Supplemen-
tary Figures S2 and S7). The involved seed-sequences in the
mRNAs as well as in IsrA seem shorter than assumed, while
extended base-pairing outwith the seed regions will be far
from specific nor energetically favorable, because this would
require disruption of a strong secondary structure in IsrA
and a conserved stem-loop in flhDC mRNA. Moreover, as
protein factors like CsrA, also bound by IsrA ((43); Figure
2A, Table 1), determine the half-life of thismessage (54), not
only IsrA association will be relevant for its upregulation.
The available data do not rule out that restricted base-pair
interactions between the seed-regions actually function to
enhance the local concentration of other factors brought by
IsrA to the targetRNA (Figure 6B). Evenmore intriguingly,
sRNPs formed by IsrA (and possibly other sRNAs) could
be delivered to mRNAs co-transcriptionally through inter-
actions with the elongating RNAP (Figure 6B). Proteins,
such as Hfq and S1, associated with IsrA were shown to in-
fluence transcription, and co-purified with RNAP (12,55–
57), which could be mediated by sRNAs.
We propose that IsrA (and possibly other sRNAs) en-
counters its target mRNAs in the form of inactive RNPs,
like in eukaryotic splicing, and deliver the needed factor(s)
that only in the context of an ‘attenuation’ complex will
be active and drive RNA transitions between translation-
competent and/or translation-incompetent and/or degra-
dation states, depending on the composition of the complex
(Figure 6B). In this model, the protein composition of the
sRNP determines the fate of the message, with the sRNA
(partly) instrumental in delivering it. The activity of RNA-
enzymes like PNPase or poly(A) polymerase PAP1 (low-
represented in the cell; see below), could thereby be con-
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trolled by ‘storing’ these enzymes in the form of sRNPs in
the cell so that their activity is only manifested when the
sRNP is in a complex with a substrate, which may hap-
pen co-transcriptionally via interaction of IsrA with RNAP
(Figure 6B).
For several sRNAs, like GcvB, MicA and RybB, a
large number of possible mRNA-targets has been identi-
fied (58,59) while IsrA has been found to act, together with
GlmZ, in a network of genes related to DNA repair (23),
indicating a wider regulatory impact of many sRNAs than
originally assumed. While we expected to find that Hfq and
CsrA co-purify with IsrA based on the available data, some
of the other proteins that were highly enriched in the IsrA-
containing fraction came as a surprise to us. This was par-
ticularly true for proteins S1, ProQ and PNPase. Bacterial
sRNAs are usually described as single agents with Hfq as
a co-factor for stabilization, but our findings indicate the
existence of various RNPs, consisting of IsrA and Hfq as a
core, which have diversified by the binding of other proteins.
Some of these, like RNAP, CsrA, S1 and ProQ can be ex-
pected to be primary IsrA-binders that would define partic-
ular sub-populations of IsrA sRNPs further specified by the
association of secondary binding proteins. In this manner,
IsrA could get involved in a multitude of processes. Note,
that unlike thewell-controlled assembly pathways needed to
synthesize the well-defined eukaryotic snRNPs, our model
allows for a more ‘fluid’ composition of bacterial sRNPs,
depending on availability of factors and their interactions.
Below we will discuss possible roles of the sRNPs formed
by IsrA.
Association of protein S1, but notmany of other 30S sub-
unit proteins, suggests specific interaction of S1 with IsrA.
The association of protein S1 with IsrA and other sRNAs
(6S RNA, CsrB, DsrA, MicF, RyhB; (13)) could indicate
that this protein, like Hfq, helps to stabilize sRNAs. Addi-
tionally, these sRNPsmight contribute to translation initia-
tion, for which 30S subunits – and thus S1- have to be on the
mRNA before it is anchored by interactions with the Shine
Dalgarno sequences and the start codon (60).
ProQ is another abundant protein that has been reported
to associate with translating ribosomes (38) and is thought
to require an RNA to upregulate translation of the trans-
porter ProP that provides osmoprotection to cells (37). Af-
ter the well-conserved Spot42 sRNA (13), IsrA would be
the second candidate to facilitate ProQ control in the ex-
pression of ProP. Absence of ProQ inhibits biofilm forma-
tion (38), which relates to some of the roles reported for IsrA
(43,53). Conservationwithin the proP 5′ UTR, is poor (Sup-
plementary Figure S8), however, making ribo-regulation
via sRNA base-pairing less likely.
Most intriguing was the co-purification of polynucleotide
phosphorylase (PNPase) with IsrA (Figure 2), although this
agrees with the finding that several other sRNAs rely for
their stability on this protein (41). PNPase is a 3′ → 5′ ex-
onuclease and part of the RNA degradosome (4) and could
have been recruited via S1 (61) or Hfq, with which it forms a
complex, together with the poly(A) polymerase PAP I (40).
The very low abundant PAP I can interact with the heli-
case CsdA (45), which also functions in ‘cold-shock’ de-
gradosomes (62). All these proteins co-purified with IsrA,
which, when overexpressed, disrupt the synthesis of curli-
fibers (an aspect of biofilm formation (21,22,53); Supple-
mentary Figure S4). The mRNA for the transcription regu-
lator of curli-synthesis, CsgD, is (one of many that are) up-
regulated in strains where PNPase or CsdA are absent (62).
IsrA is assumed to induce the degradation of csgD mRNA
(53), thus a sRNP consisting of IsrA, Hfq, S1, PAP I, PN-
Pase, CsdA and possibly RNaseG (46,47,62,63) could be
triggering csgD degradation by themselves or by providing
the platform to recruit the remaining factors needed for this.
IsrA has two conserved GGA binding sites for the post-
transcriptional regulator CsrA, which, for instance, inhibits
translation of the pgaABCD mRNA and thereby the syn-
thesis of an adhesin essential for biofilm formation. Sup-
pression of pgaABCD mRNA translation was due to CsrA
binding near the start codon or Shine-Dalgarno sequence
(43) where a stem-loop (Supplementary Figure S7A) pro-
vides a high affinity CsrA binding site (64). Overexpression
of IsrA, through its affinity for CsrA, counteracted this sup-
pression, presumably by protein titration (43). Our results
suggest a more specific mechanism, namely a direct trans-
fer of CsrA from the mRNA to IsrA in the context of a
sRNP-mRNA complex. A concomitant exchange with pro-
tein S1 or ProQ to protect the ribosome binding site of the
pgaABCD mRNA, would prime this mRNA for transla-
tion (60). Post-transcriptional upregulation of the flagellar
master regulator FlhDC by CsrA (42,54) could similarly
be mediated by IsrA (22) albeit in reverse direction: IsrA
delivering this protein when the flhDC message is encoun-
tered. GGA motifs recognized by CsrA occur frequently
within Shine Dalgarno sequences or nearby start codons
and a multitude of mRNAs – not only biofilm and motility
genes – appear to be regulated by the binding of this pro-
tein (42). The above sketched scenario of protein exchange
between target and sRNA within the context of a mRNA-
sRNP complex could therefore provide a common regula-
tory model (Figure 6B).
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